A highly experienced market access leader who excels at translating deep knowledge of complex diseases into key strategic access and reimbursement plans that achieve optimal value for assets, early pipeline through launch. Subject matter expert in global payer landscapes, HTA approaches, evidence generation plans, value messaging and pricing methodologies garnered through positions in pharma, biotech and market access consulting. Collaborative leader who enjoys building and mentoring teams. Effectively manages through cross-functional matrixed organizations.
-
Senior Director Of Market Access Rare DiseaseModerna Sep 2023 - Mar 2024Cambridge, Massachusetts, United StatesLed and coordinated value evidence generation activities that shaped access and reimbursement strategy for RD pipeline assets. Worked collaboratively with cross-functional teams to provide inputs into program design to optimize HTA acceptance -
Us Practice LeadWickenstones Ltd Jul 2020 - Aug 2023Massachusetts, United StatesBuilt the US presence for this boutique UK based market access strategy agency. As Technical Lead for the Payer Strategy team, provided guidance on proposal development through project deliverables. In concert with other practice leads, created curricula & talent development policies for staff. -
Senior Advisor, Market Access PracticeEvidera, Inc. Feb 2016 - May 2020Waltham, Ma
-
Director, Global Market AccessAbbvie Feb 2012 - Jan 2016North Chicago, Illinois, United StatesDeveloped phase appropriate global access, reimbursement and pricing strategy for assets within therapeutic portfolio. Therapeutic areas included: CNS, MS, Neuro-regeneration and remyelinating therapeutics. -
Reimbursement Director, Global Pricing & Payer PlanningAmgen Sep 2006 - Jan 2012Thousand Oaks, California, United StatesDeveloped global access and reimbursement strategy for pipeline and marketed assets. Therapeutic areas of focus: oncology (solid tumors and hematology), inflammation, cardiovascular (HF) and metabolic. -
Senior Market Access Lead, Enbrel, RheumatologyAmgen Oct 2003 - Sep 2006Thousand Oaks, California, United StatesResponsible for developing market access strategy to increase formulary acceptance. Revamped patient support services, introduced contract guidelines and designed marketing collateral for payer stakeholders.
Elsa Navarro Education Details
-
Princeton UniversityWoodrow Wilson School, Public & International Affairs
Frequently Asked Questions about Elsa Navarro
What is Elsa Navarro's role at the current company?
Elsa Navarro's current role is Market Access Strategy Leader | Biopharma and Life Sciences.
What schools did Elsa Navarro attend?
Elsa Navarro attended Princeton University.
Not the Elsa Navarro you were looking for?
-
-
Elsa Navarro
Ventura County, Ca2amgen.com, amgen.com -
Elsa Navarro
Laredo, Tx1hktronics.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial